JMP Securities Maintains Market Outperform on Sana Biotechnology, Lowers Price Target to $8
Portfolio Pulse from Benzinga Newsdesk
JMP Securities analyst Reni Benjamin maintains a Market Outperform rating on Sana Biotechnology (NASDAQ:SANA) but lowers the price target from $9 to $8.
October 12, 2023 | 3:36 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Sana Biotechnology's price target has been lowered from $9 to $8 by JMP Securities, though the Market Outperform rating is maintained.
The lowering of the price target by JMP Securities indicates a potential decrease in the short-term value of Sana Biotechnology's stock. However, the maintenance of the Market Outperform rating suggests that the company is still expected to perform well in the market relative to other stocks.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100